Distal Right Ventricular Coil Position Reduces Defibrillation Thresholds

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 10, 2003, Pages 1036-1040

  Rashba, Eric J ^a   Bonner, Matt ^b   Wilson, John ^c   Shorofsky, Stephen R ^a   Peters, Robert W ^a   Gold, Michael R ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MEDTRONIC INC   (United States)

^c TriHealth   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Defibrillation threshold; Implantable cardioverter defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTRODE; ENERGY RESOURCE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE; HEART VENTRICLE FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SUPERIOR CAVA VEIN;

AGED; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; FEMALE; HEART VENTRICLES; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0242719735     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.03205.x     Document Type: Article

References (30)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
2. Moss AJ, Zareba WJ, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary artery disease at risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
5. Haffajee C, Martin D, Bhandari A, Bardy GH, DeSouza C, Kuehlkamp V, Church T: A multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system. Jewel Active Can Investigators. Pacing Clin Electrophysiol 1997;20:215-219.
6. Gold MR, Foster AH, Shorofsky SR: Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996;78:540-543.
7. Bardy GH, Johnson G, Poole JE, Dolack GL, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B: A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
8. Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR: Comparison of single-and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998;31:1391-1394.
9. Olsovsky MR, Shorofsky SR, Gold MR: Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. J Cardiovasc Electrophysiol 1998;9:350-354.
10. Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk MM, Peters RW, Gold MR: Temporal decline in defibrillation thresholds with an active pectoral lead system. J Am Coll Cardiol 2001;38:1150-1155.
11. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ: Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation 1992;86:1206-1216.
12. Gradaus R, Block M, Seidl K, Brunn J, Isgro F, Hammel D, Hauer B, Breithardt G, Bocker D: Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: Results from active can versus array trials I and II. J Cardiovasc Electrophysiol 2001;12:921-927.
13. Kuhlkamp V, Dornberger V, Khalighi K, Mewis C, Suchalla R, Ziemer G, Seipel L: Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin Electrophysiol 1998;21:2596-2605.
14. Min X, Mehra R: Effect of RV electrode position on ventricular DFTs by finite element analysis in a human thorax model. Pacing Clin Electrophysiol 1997;20:1149.
15. De Jongh AL, Entcheva EG, Replogle JA, Booker RS, Kenknight BH, Claydon FJ: Defibrillation efficacy of different electrode placements in a human thorax model. Pacing Clin Electrophysiol 1999;22:152-157.
16. Lang DJ, Heil JE Hahn SJ, Lindstrom CC, Derfus DL: Implantable cardioverter defibrillator lead technology: Improved performance and lower defibrillation thresholds. Pacing Clin Electrophysiol 1995;18:548-559.
17. Usui M, Walcott GP, Kenknight BH, Rollins DL, Smith WM, Ideker RE: Influence on defibrillation efficacy of the malpositioning of transvenous leads with and without a subcutaneous array. Pacing Clin Electrophysiol 1994;17:784.
18. Winter J, Heil JE, Schumann C, Lin Y, Schannwell CM, Michel U, Schipke JD, Schulte HD, Gams E: Effect of implantable cardioverter/defibrillator lead placement in the right ventricle on defibrillation energy requirements. A combined experimental and clinical study. Eur J Cardiothoracic Surg 1998;14:419-425.
19. Heil JE, Kenknight BH, Derfus DL, Lang DJ: Sensing strategies dramatically affect defibrillation efficacy of endocardial based lead systems in swine. Pacing Clin Electrophysiol 1994;17:785.
20. Winter J, Schannwell CM, Zimmermann N, Dees H, Vester EG, Gradaus F, Poringe C, Conizen K, Gams E: High defibrillation energy requirements are decreased by repositioning the endocardial lead of the TRIAD lead system. Pacing Clin Electrophysiol 1999;22:802.
21. Sra J, Natale A, Axtell K, Maglio C, Jayazeri M, Deshpande S, Dhala A, Blanck Z, Akhtar M: Experience with two different non-thoracotomy systems for implantable defibrillator in 170 patients. Pacing Clin Electrophysiol 1994;17:1741-1750.
22. Gold MR, Olsovsky MR, DeGroot PJ, Cuello C, Shorofsky SR: Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiol 2000;11:25-29.
23. Sweeney RJ, Gill RM, Reid PR: Characterization of refractory period extension by transcardiac shock. Circulation 1991;83:2057-2066.
24. Efimov IR, Gray RA, Roth BJ: Virtual electrodes and deexcitation: New insights into fibrillation induction and defibrillation. J Cardiovasc Electrophysiol 2000;11:339-353.
25. Efimov IR, Cheng YN, Van Wagoner DR, Mazgalev T, Tchou PJ: Virtual electrode-induced phase singularity: A basic mechanism of defibrillation failure. Circ Res 1998;82:918-925.
26. Singer I, Lang D: Defibrillation threshold: Clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992;15:932-949.
27. Kroll MW, Tchou PJ: Testing of implantable defibrillator functions at implantation. In Ellenbogen K, ed: Clinical Cardiac Pacing and Defibrillation. Philadelphia: WB Saunders, 2000, pp. 540-561.
28. Natale A, Sra J, Axtell K, Akhtar M, Newby K, Kent V, Geiger MJ, Brandon MJ, Kearney MM, Pacifico A: Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations. Circulation 1996;93:91-98.
29. Cooklin M, Tummala RV, Peters RW, Shorofsky SR, Gold MR: Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J 1999;138:133-136.
30. Callans DJ, Swarna US, Schwartzman D, Gottlieb CD, Marchlinski FE: Postshock sensing performance in transvenous defibrillation lead systems: Analysis of detection and redetection of ventricular fibrillation. J Cardiovasc Electrophysiol 1995;6:613-615.